Abbott Laboratories (JOBS) Joins Bidding for Solvay Pharmaceuticals, Inc. Drug Unit; Deal Could be Valued at $5.9 to $7.4 Billion

Bookmark and Share

Reuters -- A bidding war around Solvay's drugs unit appeared to be emerging after a reported bid from Abbott valued the unit at up to 5 billion euros, rivalling an earlier, lower offer from Nycomed.

Back to news